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Abstract 
Diabetes is one of the leading chronic diseases affecting Australians and its prevalence 
continues to rise. Diabetes is therefore becoming a serious challenge for both the 
quality of healthcare and expenditure in the Australian healthcare system. The goal of 
this study is to investigate the development and application of DiaMonD – a diabetes 
monitoring device. Powered by pervasive technology software developed by INET, 
DiaMonD is a wireless enabled mobile phone that can facilitate superior diabetes self-
management. The development and application of DiaMonD using the Adaptive 
Mapping to Realisation methodology (AMR) methodology is examined in addition to an 
appraisal of key adoption facilitators and barriers in the Australian setting. 
Key words: healthcare, diabetes, self-management, wireless, pervasive technologies, 
Australia 
 
1 Introduction 
Diabetes is one of the leading chronic diseases affecting Australians and its prevalence 
continues to rise. The total number of diabetes patients worldwide is estimated to rise to 
366 million in 2030 from 171 million in 2000 (Wild, Roglic, Green, Sicree, & King, 
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2004). With increasingly growing prevalence which includes an estimated 275 
Australians developing diabetes daily (DiabetesAustralia, 2008), Australia is expected 
to be a significant contributor to this projected trend. In fact, an estimated 700,000 
Australians representing approximately 3.6% of the population were diagnosed with 
diabetes in 2004-05 and between 1989-90 and 2004-05 the proportion of people 
diagnosed with this disease more than doubled from 1.3% to 3.3%. Additionally, 
between 2000-01 and 2004-05, diabetes hospitalisations increased by 35% from 1,932 
to 2,608 hospitalisations per 100,000 people (AIHW, 2008). Recent statistics also show 
that for every person diagnosed with diabetes, it is estimated that there is another who 
has yet to be diagnosed which doubles the number of diabetes sufferers 
(DiabetesAustralia, 2008). Diabetes is, thus, one of the fastest growing chronic diseases 
in Australia (AIHW, 2008; Catanzariti, Faulks, & Waters, 2007; Chittleborough, Grant, 
Phillips, & Taylor, 2007).  
Diabetes can have a major impact on the quality of life of its patients and its long-term 
effects can evolve into serious complications. For instance, people with diabetes are at 
greater risk of developing cardiovascular, eye or kidney diseases, lower limb 
amputation and even reduced life expectancy than people without diabetes (AIHW, 
2008; Rasmussen, Wellard, & Nankervis, 2001; Tong & Stevenson, 2007). These 
complications can lead to death, and currently, diabetes ranks as the sixth leading cause 
of death in Australia (DiabetesAustralia, 2008) 
Evidence also shows that diabetes and its complications incur significant costs for the 
health system in Australia including costs incurred by carers, government, and the entire 
health system (DiabCostAustralia, 2002). For instance, in 2004-05 direct healthcare 
expenditure on diabetes was A$907 million which constituted approximately 2% of the 
allocatable recurrent health expenditure in that year (AIHW, 2008). Further costs 
include societal costs that represent productivity losses for both patients and their carers 
(DiabCostAustralia, 2002).  
Diabetes can, therefore, have considerable social, human, and economic impacts and 
tackling these requires solutions that substantially enhance the existing fragmented and 
uncoordinated capacity for effective prevention, early detection and management 
(VictorianGovernment, 2007). Hence, a treatment imperative is to provide patients with 
appropriate levels of monitoring to ensure containment of the disease and prevention of 
further complications. Given the exponential growth predicted for patients suffering 
from this disease coupled with the geographic spread across Australia (AIHW, 2008), a 
pervasive technology solution would offer the necessary monitoring that is both cost 
effective, convenient to both patients and clinicians and least disruptive to patient life 
style.  
Recognizing the need to have a solution that can enable the ubiquitous monitoring of 
diabetes patients while also continuously educating them, the goal of this paper is to 
investigate the development and application of DiaMonD – a diabetes monitoring 
device. Powered by pervasive technology software developed by INET, DiaMonD is a 
wireless enabled mobile phone that can facilitate superior diabetes self-management in 
the Australian setting. The realization of this goal can contribute by establishing a 
benchmark for theoretical and empirical testing. To achieve this goal, first, we provide a 
general background on the Australian health scene and critically review existing 
research. An elaboration of the proposed pervasive mobile technology solution and of 
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the anticipated barriers and facilitators the Australian setting is then provided. The 
academic rigor is achieved through various key components starting with the use of the 
chronic care model to identify support from findings the benefits and need of patient 
self-empowerment, to date not well recognised with the design of various technology 
solutions for all areas of chronic diseases, the research methodology of the refocused 
systems development model which incorporates the unique delivery framework from 
which a suitable business model is developed to support a sustained solution and the 
unique development and application of the AMR methodology. Future trends are 
subsequently discussed before the paper is concluded. 
2 Current Australian Health Scene  
Both healthcare professionals and diabetes patients require quality information if 
disease conditions are to be effectively managed. Extant research shows that there are 
several deficiencies in the information provided by the existing system for monitoring 
diabetes in Australia (Dixon & Webbie, 2006; Sprivulis et al., 2007; Swerissen & 
Taylor, 2008). First, data collected in hospitals are episode-based rather than patient-
based which makes it difficult to determine statistics concerning individual admissions, 
re-admissions, and treatment patterns. Second, there is lack of data on incidence and 
prevalence by diabetes type that can help reliably assess the magnitude of the problem. 
Third, the accuracy of recording data in administrative data sets, such as hospital 
morbidity, mortality and general practice data is uncertain. Finally, clinical management 
information is derived from uncoordinated and fragmented data collections that are not 
representative of the entire population of diabetes patients making comparison, analysis 
and trend identification difficult.  
These deficiencies are the result of the current health system set up. Based on fee-for-
service episodic doctor-patient consultation, the current Australian healthcare system 
can handle short-term illnesses involving a limited range of interventions including their 
diagnosis and treatment (Hunt, 2007). However, this system is comprised of a mixture 
of fragmented private and public healthcare subsystems that provide both healthcare 
funding and delivery. Largely uncoordinated, these subsystems are deemed to be 
unsuitable for the treatment of long-term chronic diseases including diabetes (Dixon & 
Webbie, 2006; Sprivulis et al., 2007). In particular, diabetes requires teams of various 
health professionals and long-term support to help sufferers make effective healthy 
lifestyle changes and constantly maintain them (Hunt, 2007).  
3 Current Diabetes Self-management Research 
As there is no cure for diabetes, non-medical approaches are used jointly with medical 
approaches so that patients can have a life which is as normal as possible. However, 
non-medical approaches can be challenging as they require effective lifestyle 
management and meticulous attention and monitoring by both patients and healthcare 
professionals (Britt et al., 2007). Particularly, to be successful, patients to be both 
informed and active in their treatment regimen (AIHW, 2007, 2008). This can be 
achieved by effective self-management which is a non-medical approach and which 
constitutes the focus of this paper.  
Self-management is important as it empowers diabetes patients while acknowledging 
their central role and responsibility for managing their healthcare (ICIC, 2008). Extant 
research indicates that active participation of diabetes patients in self-management is a 
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key strategy for managing their condition and reaching improved treatment outcomes 
(Colagiuri, Colagiuri, & Ward, 1998; Poulton, 1999; Rasmussen et al., 2001; Wellard, 
Rennie, & King, 2008). However, self-management is constantly time-consuming and 
requires significant self-discipline (Russell, Churl Suh, & Safford, 2005) and support 
strategies including assessment, goal-setting, action-planning, problem-solving and 
follow-up (ICIC, 2008). Moreover, because effective self-management may require 
patient interaction with various healthcare professionals, including general practitioners, 
diabetes educators, dieticians, and community nurses (Knuiman, Welborn, & 
Bartholomew, 1996), difficulties can arise when diabetes patients encounter problems 
ranging from making appointments to needing to travel to many locations (Van Eyk & 
Baum, 2002; Wellard et al., 2008; Zigbor & Songer, 2001). Given both the importance 
and complexity of applying self-management effectively for both prevention and early 
detection of diabetes, there are increasing calls for further research to facilitate self-
management (Wellard et al., 2008).  
A model proposed by Wagner (2008) requires productive interactions between informed 
and activated patients and prepared and proactive healthcare professionals (ICIC, 2008). 
One of the most important ways to achieve or at least facilitate this, entails the 
development of suitable information systems for building patient capacity to undertake 
self-management successfully (Joshy & Simmons, 2006). These information systems 
should provide the possibility for ubiquitous monitoring of an individual’s diabetes 
conditions, thereby, supporting the effective self-management of the disease. While 
being useful and easy to use so that patients can readily accept and interact with them in 
a meaningful manner, these systems also need to be robust and cost-effective to 
implement and provide auditing and benchmarking tools that are critical for the 
surveillance of patients (Joshy & Simmons, 2006). Additionally, these systems should 
provide patient summary profiles in a cost effective manner that can empower diabetes 
clinicians with the ability to manage diabetes issues on an ongoing basis to improve 
patient care (Joshy & Simmons, 2006).  
Current methods used in Australia for achieving patient self management include 
various types of training and education and support options including peer-led, generic 
and tailored chronic disease self-management planning, training and support, telephone 
coaching etc. (Francis, Feyer, & Smith, 2007; Harvey et al., 2008). Although these were 
found to be effective to various extents, they are also resource-intensive and their long-
term sustainability is questionable (Francis et al., 2007). Additionally, current research 
shows that quality improvement factors including timeliness, confidentiality, continuity, 
dignity, communication, access, education, cost, amenities and autonomy, still remain 
relatively elusive in the ambit of chronic disease services including diabetes (Tabrizi, 
Wilson, Coyne, & O'Rourke, 2008). 
Although current research has provided solutions for supporting self-management 
(Chau & Turner, 2006; Rudi & Celler, 2006) these have not always been effective due 
to the reality that “patients did not learn how to do it [apply the solutions] or they did 
not understand the rules which were explained to them, or they are not sure enough of 
their knowledge, uncertainty entailing indecision” (Reach, Zerrouki, Leclercq, & 
d'Ivernois, 2005). Nevertheless, research shows that computer-assisted telemedicine can 
help people with diabetes improve both their self-management (Balas et al., 2004) and 
their relationship with healthcare professionals (Bodenheimer, Lorig, Holman, & 
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Grumbach, 2002; Downer, Meara, Da Costa, & Sethuraman, 2006). Therefore, in this 
paper, we investigate the development and application of DiaMonD as a pervasive 
mobile technology solution to facilitate superior diabetes self-management. 
4 The Development of a Pervasive Mobile Technology 
Solution 
We propose DiaMonD – diabetes monitoring device – as a solution which incorporates 
software that facilitates the ubiquitous monitoring of an individual’s diabetes, thereby, 
contributing to diabetes self-management. The solution is grounded in trying to support 
key components of a chronic disease care model (Table 1).  
The journey began by realizing that the traditional System Development Lifecycle 
(SDLC) was fundamentally flawed for healthcare initiatives. This was due to several 
reasons including the length of time it would take to realize the final application and the 
structures and inflexible stages that had to be traversed.  Thus, INET developed a 
refocused SDLC model (figure 1a) and delivery framework (figure 1b). It was, thus, 
possible to keep the strengths of SDLC and yet move from start to finish in a much 
more compressed time frame (Table 2). 
 
Table 1 Components of Chronic Care Model (Rachlis, 2006) 
Component Description 
Organisation of Health 
System 
• Leadership in chronic disease management (CDM) 
• Goals for CDM 
• Improvement strategy for CDM 
• Incentives and regulations for CDM 
• Benefits 
Self-management support • Assessment and documentation of needs and activities 
• Addressing concerns of patients 
• Effective behaviour change interventions 
Decision Support • Evidence-based guidelines 
• Involvement of specialists in improving primary care 
• Providing education for CDM 
• Informing patients about guidelines 
Delivery System design • Practice team functioning 
• Practice team leadership 
• Appointment system 
• Follow-up 
• Planned visits for CDM 
• Continuity of Care 
Clinical Information • Registry 
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Systems • Reminders to providers 
• Feedback 
• Information about relevant subgroups of patients needing services 
• Patient treatment plans 
Community • Linkages for patients to resources 
• Partnerships with community organizations 
• Policy and plan development 
 
 
 
 
 
Figure1a: Refocused SDLC Model 
1 to 5 Years 
Traditional 1 to 5 Year 
Systems Development Life 
Cycle Project 
 
Refocus 1 to 5 year systems development 
 life cycle into small manageable pieces 
Many concurrent
eBusiness Acceleration 
Projects 
Measurable 
Benefits 
Wickramasinghe, Troshani, and Goldberg   
 
216 
Scope:
•Physician-Lead
•Commercial Sponsors
•Researchers
•Healthcare Delivery Team
Localize:
•Develop current
and new process
•Gather and 
document 
requirements 
•Develop/Customize 
Applications
•Set-up system & 
sign-off
Evaluate:
•Final Report: 
Project 
•Description 
and pre/post 
results to be 
used in 
publications Field:
•Prepare and achieve
ethics review approval
•Enroll patients.
•Acquire application licensing 
fees 
•Set-up the support
•On-ongoing support
INET Mobile E-
health Project
Actualize 
Physician-led 
Innovations In 
Chronic Disease 
Management
 
Figure 1b: Components of the Delivery Framework 
 
The research goal is to use a standardized mobile Internet (wireless) environment to 
improve patient outcomes with immediate access to patient data and provide the best 
available clinical evidence at the point of care. To achieve this, INET International 
Inc.’s research (S. e. a. Goldberg, 2002a, 2002b, 2002c, 2002d, 2002e; Wickramasinghe 
& Goldberg, 2003, 2004) starts with a 30-day e-business acceleration project in 
collaboration with many key actors in hospitals, such as clinicians, medical units, 
administration, and I.T. departments. Together, they follow a rigorous procedure that 
refocuses the traditional 1-5-year SDLC into concurrent 30-day projects to accelerate 
healthcare delivery improvements. At completion, an e-business acceleration project 
delivers a scope document to develop a handheld technology application (HTA) proof-
of-concept specific to the unique needs of a particular environment. The proof-of-
concept is a virtual lab case scenario which operates within a mobile Internet (wireless) 
environment by working with hospitals and technology vendors. The final step is the 
collection of additional data with clinical HTA trials consisting of two-week hospital 
evaluations. 
With the refocused SDLC model it was then possible to design a robust and rigorous 
web-based business model, the INET web-based business model (figure 2). This 
business model provides the necessary components to enable the delivery framework to 
be positioned in the best possible manner so it can indeed facilitate enacting the key 
components of the chronic disease model successfully (table 1). The model is positioned 
to suit the complex nature of healthcare environments by iteratively, systematically, and 
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rigorously incorporating lessons learnt data to healthcare processes for ensuring superior 
healthcare delivery. This manner does not only maximize the value of past data and 
organisational learning but it also makes processes amendable as complex needs and 
requirements evolve. 
 
INET Mobile e-Health Project SDLC 
(waterfall)  Scope Localize Field Evaluate 
I.T. Role & 
Responsibility 
Project 
Management 
Business 
Analysis 
 
Data Analysis 
Technical Tools Expert 
Programmer 
Data Administrator 
Network Architect 
Database Administrator 
Network Administrator 
Technical Support 
 
 
Account 
Manager 
Investigation Problem 
Definition 
Feasibility Study 
– can objectives 
be met at a 
reasonable cost. 
Project 
Definition 
  Document 
Solution, Data 
analysis of 
outcomes, 
benefits and 
Next Steps 
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INET Mobile e-Health Project SDLC 
(waterfall)  Scope Localize Field Evaluate 
Analysis 
(Logical Design) 
 Define what the IS must 
do to fix the problem 
Less temptation to follow 
existing practices which 
may not be best 
Define the user’s 
requirements and 
priorities Analyze existing 
system 
Develop logical design 
for the new system 
  
Design (Physical 
Design)  
 Define how the new 
system will work 
Detail Schedule and 
budget 
Produce a physical design 
showing system inputs, 
outputs, user interfaces. 
  
Implementation  Research technology 
Product Acquisitions 
Test programs, sub-
systems and systems 
acquire or develop 
software 
Code programs 
Software developer 
manual 
System operators manual 
Purchase and Install 
hardware and software 
package 
User’s Manual 
People Changeover 
Tasks 
Data Conversion. 
Technical 
Changeover Tasks 
 
Maintenance  Fix Problem/Solution 
Determination 
Fix Database, 
Network and 3rd 
Party Products 
Fix security and 
access problems 
Fix learning curve 
time disruptions 
Fix  collaboration  
problems 
 
Table 2: INET Practice Framework – Compressing the SDLC 
 
It is important to note that in this business model the three key areas of risk, namely, 
people, processes and technology, are minimised through the use of pervasive 
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technology which we believe is a unique benefit of the INET solution. Specifically, 
since the proposed solution is an application that is compatible with any mobile phone 
or wireless device (e.g. a PDA) data transfers occur between patients and providers on a 
well vetted model. Therefore, the learning curve for patients may be minimal as they are 
likely to be in possession of mobile devices. 
 
 
Figure 2: INET web-based model 
 
Successful web-based projects in healthcare require the consideration of many 
components.  Figure 2 provides an integrative model for all key success factors that we 
have identified through our research (S. e. a. Goldberg, 2002a, 2002b, 2002c, 2002d, 
2002e; Wickramasinghe & Goldberg, 2004; Wickramasinghe & Misra, 2004; 
Wickramasinghe, Schaffer, & Geisler, 2005). What makes this model unique and most 
beneficial is its focus on enabling and supporting all areas necessary for the 
actualization of ICT initiatives in healthcare. By design, the model identifies the inputs 
necessary to bring an innovative chronic disease management solution to market. These 
solutions are developed and implemented through a physician-led mobile e-health 
project. This project is the heart of the model that bridges the needs and requirements of 
many different players into a final (output) deliverable, a “Wireless Healthcare 
Program”.  To accomplish this, the model is continually updated to identify, select and 
prioritize the ICT project inputs that will: 
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? Accelerate healthcare system enhancements and achieve rapid healthcare benefits. 
The model identifies key healthcare system inputs with the four Ps, namely, 1) 
People that deliver healthcare, 2) Process to define the current healthcare delivery 
tasks, 3) Platform used in the healthcare technology infrastructure, and 4) 
Protection of patient data.    
? Close the timing gaps between information research studies and their application in 
healthcare operational settings.  
? Shorten the time cycle to fund an ICT project and receive an adequate return on the 
investment. 
 
Together the components of the model will help in actualizing physician-led solution for 
the management of chronic diseases in general and of diabetes in particular. The 
delivery framework activities (Figure 1a and 2) are ongoing and represent a continuous 
improvement cyclical approach towards a given wireless healthcare program. These 
activities however require the relevant and complete inputs from the healthcare system 
if they are to be carried out successfully. With the refocused SDLC in constructing 
mobile e-health solutions, both the healthcare inputs (i.e. the four Ps) and the delivery 
framework may require funding from various sources in return for healthcare 
improvements and the building up of intelligence in terms of relevant research findings. 
To successfully implement the business model described above it was, however, 
necessary to have an appropriate methodology. Based on this need the adaptive 
mapping to realization methodology (AMR) was developed (figure 3). The idea of the 
methodology was to apply a systematic rigorous set of predetermined protocols to each 
business case and then map the post-prior results back to the model. In this way, it was 
possible to compare and contrast both a priori and post priori findings. From such a 
comparison a diagnosis of the current state was made and then prescriptions were 
derived for the next business case. Hence, each pilot study incorporated the lessons 
learnt from the previous one and the model was adapted in real time. 
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Figure 3: AMR Methodology 
By applying the tools and techniques of today’s knowledge economy as presented in the 
intelligence continuum (IC) it is possible to make the AMR methodology into a very 
powerful knowledge-based systems development model (figure 4). The IC was 
developed by Wickramasinghe and Schaffer (2006) to enable the application of tools 
and technologies of the knowledge economy to be applied to healthcare processes in a 
systematic and rigorous fashion and thereby ensure superior healthcare delivery. The 
collection of key tools, techniques and processes that make up the IC include but are not 
limited to data mining, business intelligence/analytics and knowledge management 
(Wickramasinghe & Schaffer, 2006).  
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Figure 4: Knowledge-based Systems Development Model 
 
Taken together, they represent a very powerful system for refining the raw data stored 
in data marts and/or data warehouses and thereby maximizing the value and utility of 
these data assets for any organization. To maximize the value of the data generated 
through specific healthcare processes and then use this to improve processes, IC 
techniques and tools must be applied in a systematic manner. Once applied, the results 
become part of the data set that are subsequently reintroduced into the system and 
combined with other inputs of people, processes, and technology to develop an 
improvement continuum. Thus, the IC includes the generation of data, the analysis of 
these data to provide a “diagnosis”, and their reintroduction into the cycle as a 
“prescriptive” solution. In this way, the IC is well suited to the dynamic and complex 
nature of healthcare environments and ensures that the future state is always built upon 
the extant knowledge-base of the preceding state. Through the incorporation of the IC 
with the AMR methodology we then have a knowledge-based systems development 
model that can be applied to any setting, not necessarily to chronic disease management. 
The power of this model is that it brings best practices and the best available germane 
knowledge to each iteration and is both flexible and robust. 
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Figure 5: ICT Support for Diabetes 
 
Figure 5 describes succinctly the INET solution where patients in the program submit 
glucose readings through their cell phones. The patients’ primary care physician 
subsequently reviews the results and makes recommendations, which are transmitted 
back to the patients’ cell phones for review. This is an alternative method of 
communication between the patient and primary care physician to support the control of 
patient’s diabetes. The patient creates a bookmark in their cell phone, and then using a 
unique patient ID, they gain access to an application to quickly enter glucose readings 
and access messages. The physician is given an internet link, and using their unique 
physician ID, he or she can quickly access a list of patients, trends and a simple way to 
send messages. 
Thus, DiaMonD represents a pervasive ICT enabled solution which while not 
exorbitantly expensive it facilitates the superior monitoring of diabetes (figure 5). The 
proposed solution enables patient empowerment by way of enhancing self-management. 
This is a desirable objective because it allows patients to become equal partners with 
their clinicians in the management of their own healthcare (Opie, 1998; Radin, 2006) by 
enhancing the traditional clinical-patient interactions (Mirza, Norris, & Stockdale, 
2008). However, because most work has focused on specific applications and proof-of-
concept studies, this paper would be incomplete without considering the critical success 
factors, including facilitators and barriers, that are expected to affect the ubiquitous 
adoption of the proposed solution in the Australian setting (Gururajan & Murugesan, 
2005; Mirza et al., 2008). 
5 Anticipated Barriers and Facilitators in Australia  
In order to move smoothly from idea to realisation, we identify and discuss seven 
factors that may impede or facilitate the success of DiaMonD in the Australian setting. 
First, DiaMonD has the potential to reduce face-to-face interaction between patients and 
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their clinicians. While this may be favourable for some patients, it may impact on the 
social needs of others for human interaction. This may lead to resistance or even 
rejection for adopting DiaMonD at both conscious and subconscious levels (Vanjara, 
2006). However, we argue that DiaMonD incorporates mobile phones which are 
perceived to confer a social status amongst some segments of society which may well 
become an adoption facilitator. Furthermore, usage of mobile phones may also help 
eliminate the social stigma that can occur with alternative obvious devices that are used 
for monitoring chronic diseases (Mirza et al., 2008).  
Second, mobile phones are location-independent which makes healthcare monitoring 
both flexible and ubiquitous, that is, not confined to specific settings, such as hospitals 
(Istepanian & Lacal, 2003). While also generating potentially significant cost savings 
(e.g. by reducing false positive or non serious hospitalisations) for managing the care of 
non-critical diabetes sufferers DiaMonD will also improve their quality of life 
(Istepanian, Jovanov, & Zhang, 2004; Mirza et al., 2008; Norris, 2002). This may, thus, 
facilitate DiaMonD adoption. 
Third, the ageing population in Australia combined with the fragmented nature of the 
Australian healthcare system that is designed to treat episodic conditions, and the 
generally poor awareness of life style implications will increase the pressure on this 
system for better chronic disease treatment standards over longer periods (ABS, 2003; 
Rowland, 2003). The pervasive nature of DiaMonD combined with its ability to offer 
targeted and tailored health messages can contribute to ease that pressure, and 
consequently, become a facilitator for its adoption in Australia (Neville, Greene, 
McLeod, & Tracy, 2002).  
Fourth, there is evidence suggesting that to date, some sectors of the healthcare system 
in Australia have not been convinced of the benefits of ICT in general and pervasive 
mobile solutions in particular (Yu, Li, & Gagnon, 2008). At least partially, this is due 
clinicians’ preference and bias towards traditional face-to-face forms of interactions 
with their patients (Skulimowski, 2006). Furthermore, in a recent study, Australian 
nurses and clinicians considered that the vast majority of employers did not encourage 
ICT training, and for those for whom training was available, heavy workloads were 
considered to be major barriers for training uptake (Eley, Fallon, Soar, Buikstra, & 
Hegney, 2008). Taken together, these factors are expected to become barriers for the 
adoption of DiaMonD. Organisational changes, including establishment or awareness 
and training are, thus, required for extended adoption and diffusion (Mirza et al., 2008). 
Fifth, DiaMonD is expected to be highly cost-effective for people with diabetes. For 
example, costs to patients are estimated to be confined to data transfer charges which 
include the systematic texting (e.g. by SMS) of glycemic levels (measured by HA1C 
readings). With increasing competition amongst Australian operators, data transfer 
charges are expected to decrease in the future (Troshani & Rao, 2007a). Another 
possible cost to patients may include mobile handset acquisition. However, with a very 
high mobile penetration rate in Australia, diabetes patients are likely to already be in 
possession of mobile phones (Rao & Troshani, 2007a, 2007b). Nevertheless, DiaMonD 
may require investment outlays from health providers. Initial setup, operational, and 
supporting infrastructure costs may be barriers for its smooth adoption in Australia 
(Khambati, Warren, Grundy, & Hosking, 2008). 
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Sixth, legislation and perceptions of security and privacy are likely to have a strong 
bearing on the successful adoption of DiaMonD in Australia. Although, the model 
underpinning DiaMonD accounts for protection of patient information in terms of 
privacy, security, and reliability, both individual and organisational adopters are 
expected to require solid guarantees that continuous security improvements will reliably 
safeguard the privacy of patient data. Nevertheless, extant research shows that these 
concerns may dissipate overtime as mobile technology matures and benefits and 
convenience begin to be experienced on a wide scale (Mirza et al., 2008). 
Finally, other factors that, in various forms, may become barriers for the adoption of 
DiaMonD in Australia include existing disparate legacy systems and possible 
integration costs, lack of standards and limited bandwidth (Mirza et al., 2008). 
Additionally, prioritisation and decision-making processes concerning the introduction 
and diffusion of new health technologies in some areas in Australia are described to be 
‘ad-hoc’ (Gallego, Fowler, & van Gool, 2008). Budgetary constrains often drive uptake 
and diffusion of new technologies (Gallego et al., 2008). 
6 Discussion 
Modern healthcare delivery can benefit from the incorporation of various technology 
enabled solutions. The preceding sections have served to describe and highlight the 
example of DiaMonD – a pervasive wireless technology solution.  We stress that we use 
the name of the product not as a marketing ploy but rather to show that it is possible to 
create superior technology enabled solutions that are simple and inexpensive. More 
importantly, in many ways the strengths of this paper are not in the product or the 
solution but rather its academic rigor. The vast majority of healthcare technology 
solutions are developed and trailed by pharmaceutical companies and /or vendors. In 
this instance we describe an independent research study. From the very onset where the 
justification of patient self-empowerment was grounded in literature and the chronic 
care model to the development of the revised systems development model for the 
initiation and expansion of the physician-led pilot studies to the conceptualisation and 
design of the delivery framework which ensures both tailoring to the local context and 
yet a standard framework that thus support both between and within comparisons of 
directional data and randomised control trials, to the defining of a suitable business 
model to ensue that the solution is in fact sustainable to the role and incorporation of the 
AMR methodology to enable continuous improvement and the power of the tools and 
techniques of the knowledge economy to be accessed and utilised to ensure that the 
solution provided to patients is at all times derived from the best set of inputs and the 
latest knowledge. This in turn ensures that the principles of evidence based medicine are 
adhered to, something that one cannot validate externally when trials and research are 
being conducted by third parties such as vendors  or pharmaceutical companies. 
This paper then stands apart from the majority of healthcare IS/IT papers that describe a 
technology solution to address a healthcare problem in that it develops an objective set 
of criteria to measure success in a systematic fashion. Hence in the Australian context it 
is essential that the delivery framework be defined to capture the key and unique 
elements of the context as well as maintain the essential strengths of the solution. For 
example under: 1) scope -  it would be necessary to investigate in the long term the role 
healthcare insurance companies would play; would they provide rebates or not for this 
treatment and/or would this rebate be provide through Medicare, 2: Localize – it would 
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be necessary to gather documents pertaining to current practices in Australia what is 
considered appropriate blood readings and whether these differed from other standards; 
3) Field – it is necessary to undergo relevant and appropriate ethical clearance in the 
Australian context; 4) Evaluate – this would require several levels including comparing 
and contrasting directional data and data from randomised control trials to those of 
studies in other countries, across multiple studies within Australia and looking at 
patients with different diabetic conditions as well as within the one study. In addition, it 
would be essential to continuously update the inputs so as to preserve the AMR 
methodology.  
It is also important to note that the approach and elements described in this paper can be 
used in other contexts in healthcare with other technologies. Thus, we believe another 
contribution of this paper is to recommend that a suitable approach for applied research 
initiatives in healthcare is to follow the essential steps we have outlined in this paper as 
follows: 1) ground the role for the technology in a medical need that is identified in the 
literature – e.g. in this study we have identified patient self-empowerment as identified 
in the chronic care model, 2) look at existing established models and adapt them if 
required rather than just move forward – ie the use of the refocused SDLC model,  3) 
design a robust delivery framework that is flexible and yet robust to apply in various 
contexts so as to facilitate between and within group comparisons of data, 4) design an 
appropriate business model that ensures a sustained solution – for healthcare nothing is 
worse than to offer patients a superior solution for only a short time – i.e. the use of the 
web-based model, 5) incorporate the tools and techniques of the knowledge economy – 
given the push to evidence-based medicine and the vast amount of data and information 
in healthcare this is essential – i.e. the use of AMR methodology. 
7 Future Developments 
Given the general global consensus that effective and efficient healthcare delivery will 
only occur through the judicious application of ICTs (FS, 2004; Kulkarni & Nathanson, 
2005; Lacroix, 1999; Porter & Tiesberg, 2006; Wickramasinghe, 2007), it is inevitable 
that, as we move into the second decade of the 21st century, the prevalence of ICTs to 
facilitate the delivery of value driven healthcare will increase. We believe in such a 
climate DiaMonD will be even more appropriate not only because it utilises ICTs to 
provide superior healthcare delivery in the case of diabetic patients but it is also simple 
to implement and use and cost effective both at the micro and macro levels. These levels 
include both individual patients and clinicians and organisations including public and 
private healthcare providers.  
Nevertheless, it is anticipated that increased adoption and diffusion of chronic disease 
mobile self-management solutions may depend increasingly less on technology and 
increasingly more on acceptability by both patients and clinicians, on the one hand, and 
on organisational healthcare providers, on the other. Clearly, mobile solutions such as 
DiaMonD need to suit and be consistent with both patient lifestyles and work practices 
undertaken by clinicians within healthcare provider organisations. This may be 
indicative that education programs and promotional campaigns may need to be 
undertaken for enhancing awareness and incentivising adoption. Tested processes and 
procedures will result that greatly facilitate the creation of personal medical records and 
effective and efficient forms of interaction with patients who suffer from a very 
debilitating chronic disease such as diabetes. 
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We also believe that the model underlying DiaMonD can be extended and adapted to 
provide the necessary monitoring and self-management to other chronic diseases 
including but not limited to hypertension, cardiac conditions and obesity. Diseases of 
this nature require daily tests and continuous monitoring which are typically essential to 
recommended treatment. However, widespread adoption and diffusion of mobile self-
management solutions for chronic disease management also implies that practical steps 
may need to be undertaken in the future concerning the development, implementation, 
and evaluation of information standards as well as subsequent integration with 
healthcare legacy systems. 
The effective application of wireless solutions such as DiaMonD entails the existence of 
a trusting environment amongst all stakeholders including patients, physicians, insurers 
and government. A trusting environment constitutes an important factor in the adoption 
of DiaMonD and diabetes self-management service it provides. Trust determines the 
patients’ expectations in their relationships with their healthcare providers, and it 
increases their perceived certainty concerning the provider’s expected behaviour. More 
generally, trust is essential in all economic activities where undesirable opportunistic 
behaviour is likely to occur (Gefen, Karahanna, & Straub, 2003). However, trust 
becomes particularly vital in a mobile environment in a healthcare setting, where 
situational factors such as uncertainty or risk and information asymmetry are present 
(Ba & Pavlou, 2002). On the one hand, patients maybe unable to judge the 
trustworthiness of healthcare providers, and on the other, the latter can also easily take 
advantage of the former by engaging in harmful opportunistic behaviours. For example, 
healthcare providers can engage in illicit behaviours including selling or sharing the 
personal information of its patients.  
There are two key elements in any trusting environment including healthcare, namely, 
security and privacy (Lu, Yu, Liu, & Yao, 2003). Security encompasses confidentiality, 
authentication, and message integrity. Because DiaMonD can have limited computing 
resources and wireless transmissions are more susceptible to hacker attacks, security 
vulnerabilities can have serious consequences (Galanxhi-Janaqi & Nah, 2004; Lu et al., 
2003). These can be particularly serious in a healthcare setting. There are several 
remedies against the dangers of insecurity. For example, public key infrastructure and 
certification authorities which use public key cryptography to encrypt and decrypt 
mobile transmissions and authenticate both patients and healthcare providers.  
Ironically, the same information practices which provide value to both patients and 
healthcare providers also cause privacy concerns. Some of these concerns include: the 
type of information that can be collected about patients and the ways in which it will be 
protected; the stakeholders and entities that can access this information and their 
accountability; and the ways in which the information will be used (Galanxhi-Janaqi & 
Nah, 2004). In healthcare settings where solutions such as DiaMonD are used, a trusting 
environment can be encapsulated in perceived credibility (Lin & Wang, 2005; Wang, 
Wang, Lin, & Tang, 2003). Evidence shows that there is a significant direct relationship 
between perceived credibility and the intention to adopt general mobile services (Lin 
and Wang, 2005, p. 410). However, we call for further research to test if this 
relationship holds true in healthcare settings as well. 
Finally, we are investigating the possibility of combining the wireless self-management 
initiative with a community support perspective. Specifically, future research is 
Wickramasinghe, Troshani, and Goldberg   
 
228 
currently being directed to investigate the manner in which social networks can be used 
jointly with DiaMonD to facilitate healthcare delivery (S. Goldberg, 2009). Particularly, 
we believe that this can be achieved through the development of diabetes patient’s own 
social network (e.g. in Facebook). In this way, we will not only be empowering diabetes 
patients to take control and responsibility for monitoring and managing their own care 
(i.e. via DiaMonD) but also making available to them as conveniently and as 
unobtrusively as possible access to the necessary community support via their social 
networks. Preliminary trials offer encouraging findings (S. Goldberg, 2009). We firmly 
believe that such a model has large and far reaching implications for delivery of care in 
general as well as the economics of healthcare delivery and further research is current 
underway.  
8 Conclusions  
We set out to present a case for the need to embrace a pervasive technology solution for 
the superior monitoring of diabetes self-management for patients in Australia. 
Developed by INET, we have argued that DiaMonD is a suitable wireless solution for 
many reasons including that it is equally successful in controlling both type I and type II 
diabetes, is as effective irrespective of patient’s age, socio economic standing or 
location and has minimal risks and a very slight learning curve (if at all). We contend 
that if such DiaMonD and its underlying model were to be incorporated into the 
Australian context the growing segment of the population suffering from diabetes would 
have a convenient, cost effective and superior means of monitoring and thereby 
controlling their diabetes while in turn enjoying a better quality of life.  
DiaMonD facilitates governments, associations, pharmaceutical firms, researchers, 
healthcare professionals and other healthcare stakeholders that are looking for improved 
and measurable outcomes among patients suffering from diabetes. Specific benefits 
range from decreasing diabetes related complications to reducing the economic burden 
on the health system. We realise that further research is required to test DiaMonD in the 
Australian healthcare setting including testing of aspects, such as perceived ease of use, 
perceived usefulness, etc. Nevertheless, we conclude by warning that if a pervasive 
technology solution is not sought for the monitoring and support of diabetes self-
management not only will this chronic disease become a silent epidemic but it will also 
be a very costly burden for both the healthcare sector and the community at large.  
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